BPH - Benign Prostatic Enlargement - Results from #640

REVIEW UroToday

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia. May 16, 2021

Comparison of long-term effect and complications between holmium laser enucleation and transurethral resection of prostate: Nations-wide health insurance study. May 10, 2021

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial. May 9, 2021

The PLASMA System for Transurethral Resection of the Prostate: A NICE Medical Technologies Guidance Update. May 3, 2021

Transurethral Prostatectomy Before or After External Beam Radiotherapy: Complications and Reoperation Rates. May 3, 2021

Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of Rezūm Water Vapor Thermal Therapy for Treatment of Moderate-To-Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. April 26, 2021

Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain. April 25, 2021

Is it time to offer True Minimally Invasive Treatments (TMIST) for BPH? - A review of office-based therapies and introduction of a new technology category. April 25, 2021

M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown. April 19, 2021

Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study. April 19, 2021

Men's Health: Benign Prostatic Hyperplasia. April 19, 2021

Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 Evaluation. April 18, 2021

Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety. April 12, 2021

The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review. April 12, 2021

Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. April 12, 2021

One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia. April 11, 2021

Prostatic Artery Embolization to Achieve Freedom from Catheterization in Patients with Acute Urinary Retention Caused by Benign Prostatic Hyperplasia. April 5, 2021

Plasma kinetic enucleation vs holmium laser enucleation for treating benign prostatic hyperplasia: a randomized controlled trial with a 3-year follow-up. April 5, 2021

Cardiac Failure Associated with Medical Therapy of Benign Prostatic Hyperplasia: A Population Based Study. April 5, 2021

In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia. March 29, 2021

Page 33 of 140